OR WAIT null SECS
September 21, 2017
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
August 22, 2017
CDMO Micro-Sphere is investing CHF 21 million (approximately $21.63 million) into the expansion of its GMP manufacturing capabilities at its Swiss facility.
June 05, 2017
Cambrex announces expansions of its North Carolina API pilot plant and Kalskoga, Sweden large-scale manufacturing facility.
March 17, 2017
Caladrius is selling the remaining percentage of the subsidiary in order to focus on cell therapy development.
November 28, 2016
Catalent adds two softgel facilities and packaging capabilities with acquisition of Canada-based Accucaps.
Patheon adds API manufacturing capacity with acquisition of Roche’s Florence, SC facility.
November 02, 2016
Recipharm is investing more than EUR1.2 million to enhance its small-scale GMP API development and manufacturing capabilities in Paderno Dugnano, Italy.
August 16, 2016
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
August 01, 2016
Bio/pharmaceutical contract service provides continue to invest in development, facility upgrades, technological advancement, and mergers and acquisitions.
March 10, 2016
Hovione will operate a commercial-scale continuous manufacturing facility in New Jersey as part of an agreement with Vertex Pharmaceuticals.